Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-15.52%
operating margin TTM
-15.28%
revenue TTM
333.46 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | -1.40 |
| peg ratio | -0.27 |
| price to book ratio | 23.82 |
| price to sales ratio | 0.22 |
| enterprise value multiple | -1.95 |
| price fair value | 23.82 |
profitability ratios | |
|---|---|
| gross profit margin | 35.11% |
| operating profit margin | -15.28% |
| pretax profit margin | -16.44% |
| net profit margin | -15.52% |
| return on assets | -35.34% |
| return on equity | -272.61% |
| return on capital employed | -49.89% |
liquidity ratio | |
|---|---|
| current ratio | 2.15 |
| quick ratio | 1.96 |
| cash ratio | 0.95 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 14.35 |
| operating cycle | 59.52 |
| days of payables outstanding | 34.78 |
| cash conversion cycle | 24.74 |
| receivables turnover | 8.08 |
| payables turnover | 10.49 |
| inventory turnover | 25.43 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 8.36 |
| long term debt to capitalization | 0.87 |
| total debt to capitalization | 0.89 |
| interest coverage | -8.02 |
| cash flow to debt ratio | -0.88 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.40 |
| cash per share | 0.66 |
| operating cash flow per share | -0.35 |
| free cash flow operating cash flow ratio | 1.14 |
| cash flow coverage ratios | -0.88 |
| short term coverage ratios | -3.90 |
| capital expenditure coverage ratio | -7.00 |
Frequently Asked Questions
When was the last time The Oncology Institute, Inc. (NASDAQ:TOI) reported earnings?
The Oncology Institute, Inc. (TOI) published its most recent earnings results on 13-11-2024.
What is The Oncology Institute, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. The Oncology Institute, Inc. (NASDAQ:TOI)'s trailing twelve months ROE is -272.61%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. The Oncology Institute, Inc. (TOI) currently has a ROA of -35.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TOI's net profit margin stand at?
TOI reported a profit margin of -15.52% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TOI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.15 in the most recent quarter. The quick ratio stood at 1.96, with a Debt/Eq ratio of 8.36.